CAS号:58186-27-9
品名:艾地苯醌idebenone
中文别名:2-(10-羟基癸基)-5,6-二甲氧基-3-甲基-1,4-苯醌;艾地苯;2-(10-羟基癸基)-5,6-二甲氧基-3-甲基-2,5-环己二烯-1,4-二酮;6-(10-羥癸)-2,3-二甲氧-5-甲-1,4-苯醌;
英文别名:Idebenone;Idebenona[Spanish];CV2619;2-(10-hydroxydecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione;UNII-HB6PN45W4J;2,3-dimethoxy-5-methyl-6-(10'-hydroxydecyl)-1,4-benzoquinone;2-(10-hydroxydecyl)-5,6-dimethoxy-3-methyl-cyclohexa-2,5-diene-1,4-dione;Idebenone[INN:JAN];2-(10-hydroxydecyl)-5,6-dimethoxy-3-methylbenzo-1,4-quinone;Idebenonum[Latin];
分子式:C19H30O5
分子量:338.439
精确质量:338.209
Psa:72.83
RTECS号:GU5290000
UNII号:HB6PN45W4J
外观与性状:从石油醚得橙色针状结晶,熔点46~50℃。从己烷-乙酸乙酯得结晶,熔点52~53℃。极易溶于氯仿、甲醇或无水乙醇,易溶于乙酸乙酯,溶于多数有机溶剂,难溶于正己烷,几不溶于水。
密度:1.08 g/cm3
沸点:497.3ºC at 760 mmHg
熔点:52-550C
闪点:170.1ºC
折射率:1.502
稳定性:Stable at normal temperatures and pressures.
储存条件:Room temp
危险品标志:Xi
简介:Idebenone(tradenamesCatena,Raxone,Sovrima,amongothers)isadrugthatwasinitiallydevelopedbyTakedaPharmaceuticalCompanyforthetreatmentofAlzheimer'sdiseaseandothercognitivedefects.Thishasbeenmetwithlimitedsuccess.TheSwisscompanySantheraPharmaceuticalshasstartedtoinvestigateitforthetreatmentofneuromusculardiseases.In2010,earlyclinicaltrialsforthetreatmentofFriedreich'sataxiaandDuchennemusculardystrophyhavebeencompleted.AsofDecember2013[update]thedrugisnotapprovedfortheseindicationsinNorthAmericaorEurope,butitisapprovedforthetreatmentofLeber'shereditaryopticneuropathy(LHON)inEurope.
用途:艾地苯醌慢性脑血管病及脑外伤等所引起的脑功能损害。能改善主观症状、语言、焦虑、抑郁、记忆减退、智能下降等精神行为障碍。
其他分子